Chemical Structure : ERG245
货号: PC-26615Not For Human Use, Lab Use Only.
ERG245 is a potent, selective BCAT1 inhibitor with IC50 of 0.5 nM for recombinant human BCAT1 (rhBCAT1), >2000-fold selectivity for BCAT1 over BCAT2.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ERG245 is a potent, selective BCAT1 inhibitor with IC50 of 0.5 nM for recombinant human BCAT1 (rhBCAT1), >2000-fold selectivity for BCAT1 over BCAT2.
ERG245 completely suppressed production of IFNg and granzyme B (GZMB) in activated CD8+ T cells, shows partial inhibition of CD8+ T cell expansion for murine CD8+ (mCD8+).
ERG245 metabolically reprograms the cells towards increased OXPHOS. suppresses activation of CD8+ T cells in DSS colitis leading to improved disease outcomes.
ERG245 dramatically increases anti-PD-1 efficacy inducing complete and durable tumor regressions in the moderately immunogenic CT26 tumor model.
| 分子量 | 347.21 | |
| 分子式 | C17H15BrO3 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Lodi F, et al. bioRxiv, 2023: 2023.02. 25.530034.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright